keyboard_backspace Back

Hematologic Malignancies in Critical Care

a review

The lecture duration is 29min.

0.5 CPD Points, 0.5 CEUs, 0.5 CME credits approval pending.
Accredited by CPDUK, CBRN and Provider Pending.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Jenna Spring
Specialist in Oncologic Critical Care at Sinai Health, University off Toronto, Canada
Lecture Summary

Critical illness is common among patients with hematologic malignancy and may arise due to complications from treatment or the underlying disease. ICU outcomes for this patient population have significantly improved in recent decades and there are multiple emergencies that are essential for critical care clinicians to recognize and promptly treat. This talk will discuss the approach to the following complications in detail: hyperleukocytosis and leukostasis, acute promyelocytic leukemia, tumor lysis syndrome, febrile neutropenia and neutropenic sepsis.

Target Audience

Critical Care Doctors
Experienced or advanced Critical Care Nurses

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Describe the incidence and prognosis of critical illness in patients with hematologic malignancy
  • Discuss a practical approach to for key hematological emergencies

None.